$REFI
Chicago Atlantic Real Estate Finance, Inc. Stock $refi

$refi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023037447 Filed on May 09, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$13.66M	$14.91M	$9.833M
YoY Change	19.86%	51.62%
Cost Of Revenue	$994.9K	$1.618M	$72.27K
YoY Change	121.31%	2139.24%
Gross Profit	$13.66M	$14.91M	$9.761M
YoY Change	19.86%	52.74%
Gross Profit Margin	100.0%	100.0%	99.27%
Selling, General & Admin	$3.882M	$20.27M	$1.905M
YoY Change	34.27%	964.02%
% of Gross Profit	28.41%	135.99%	19.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$5.021M	$4.217M	$1.957M
YoY Change	27.54%	115.48%
Operating Profit	$8.643M	$10.69M	$7.804M
YoY Change	15.8%	37.01%
Interest Expense	$871.4K	$1.441M
YoY Change	215.09%
% of Operating Profit	10.08%	13.48%
Other Income/Expense, Net	$1.280M
YoY Change	64.74%
Pretax Income	$8.643M	$10.69M	$7.804M
YoY Change	15.8%	37.01%
Income Tax
% Of Pretax Income
Net Earnings	$8.643M	$10.69M	$7.804M
YoY Change	15.8%	37.01%
Net Earnings / Revenue	63.26%	71.72%	79.36%
Basic Earnings Per Share	$0.48	$0.60	$0.44
Diluted Earnings Per Share	$0.47	$0.60	$439.7K
COMMON SHARES
Basic Shares Outstanding	18.09M shares	18.08M shares	17.64M shares
Diluted Shares Outstanding	18.27M shares	17.96M shares	17.74M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.02M	$4.641M	$6.078M
YoY Change	172.09%	-23.65%
Cash & Equivalents	$18.02M	$4.641M	$6.078M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$994.8K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$19.27M	$6.547M	$6.094M
YoY Change	154.23%	7.43%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$877.6K
YoY Change
Other Assets	-$5.122M	-$4.052M	$795.8K
YoY Change		-609.2%
Total Long-Term Assets	$311.3M	$316.3M	$279.8M
YoY Change	-5.66%	13.05%
TOTAL ASSETS
Total Short-Term Assets	$19.27M	$6.547M	$6.094M
Total Long-Term Assets	$311.3M	$316.3M	$279.8M
Total Assets	$330.6M	$322.9M	$285.9M
YoY Change	-2.07%	12.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.416M	$962.2K	$571.8K
YoY Change	165.25%	68.26%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$315.6M	$313.7M
YoY Change	-4.94%
Total Short-Term Liabilities	$11.92M	$11.77M	$8.369M
YoY Change	-29.1%	40.61%
LONG-TERM LIABILITIES
Long-Term Debt	$43.00M	$37.50M	$0.00
YoY Change	-4.44%
Other Long-Term Liabilities	$1.944M	$1.490M	$8.154M
YoY Change	-72.66%	-81.73%
Total Long-Term Liabilities	$44.94M	$38.99M	$8.154M
YoY Change	-13.75%	378.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.92M	$11.77M	$8.369M
Total Long-Term Liabilities	$44.94M	$38.99M	$8.154M
Total Liabilities	$56.87M	$50.76M	$16.52M
YoY Change	-17.5%	207.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.898M	-$2.983M
YoY Change	720.77%
Common Stock	$181.8K	$180.9K
YoY Change	2.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$273.7M	$272.1M	$269.4M
YoY Change
Total Liabilities & Shareholders Equity	$330.6M	$322.9M	$285.9M
YoY Change	-2.07%	12.93%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$8.643M	$10.69M	$7.804M
YoY Change	15.8%	37.01%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$10.21M	$1.702M	$3.036M
YoY Change	135.32%	-43.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$5.198M	$25.32M	-$77.18M
YoY Change	-112.51%	-132.8%
Cash From Investing Activities	$5.198M	$25.32M	-$77.18M
YoY Change	-112.51%	-132.8%
FINANCING ACTIVITIES
Cash Dividend Paid		$13.49M	$4.512M
YoY Change		198.87%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.029M	-$28.09M	-30.61K
YoY Change	-105.37%	91680.06%
NET CHANGE
Cash From Operating Activities	10.21M	$1.702M	3.036M
Cash From Investing Activities	5.198M	$25.32M	-77.18M
Cash From Financing Activities	-2.029M	-$28.09M	-30.61K
Net Change In Cash	13.38M	-$1.075M	-74.17M
YoY Change	2355.37%	-98.55%
FREE CASH FLOW
Cash From Operating Activities	$10.21M	$1.702M	$3.036M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	refi	Risk Rating Three RiskRatingThree		usd
CY2020Q1	refi	Risk Rating Three RiskRatingThree		usd
CY2019Q1	refi	Risk Rating Three RiskRatingThree		usd
CY2020Q4	refi	Risk Rating Three RiskRatingThree		usd
CY2019Q4	refi	Risk Rating Three RiskRatingThree		usd
CY2023Q1	refi	Risk Rating Four RiskRatingFour		usd
CY2022Q1	refi	Risk Rating Four RiskRatingFour		usd
CY2020Q1	refi	Risk Rating Four RiskRatingFour		usd
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami Beach
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33139
CY2023Q1	dei	City Area Code CityAreaCode	(312)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	809-7002
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	REFI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q1	refi	Risk Rating Four RiskRatingFour		usd
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q4	refi	Risk Rating Four RiskRatingFour		usd
CY2020Q4	refi	Risk Rating Four RiskRatingFour		usd
CY2019Q4	refi	Risk Rating Four RiskRatingFour		usd
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	refi	Risk Rating Five RiskRatingFive		usd
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18088683	shares
CY2023Q1	refi	Loans Held For Investment LoansHeldForInvestment	316226144	usd
CY2022Q4	refi	Loans Held For Investment LoansHeldForInvestment	339273538	usd
CY2022Q1	refi	Risk Rating Five RiskRatingFive		usd
CY2021Q1	refi	Risk Rating Five RiskRatingFive		usd
CY2020Q1	refi	Risk Rating Five RiskRatingFive		usd
CY2019Q1	refi	Risk Rating Five RiskRatingFive		usd
CY2023Q1	refi	Current Expected Credit Loss Reserve CurrentExpectedCreditLossReserve	-4051934	usd
CY2022Q4	refi	Current Expected Credit Loss Reserve CurrentExpectedCreditLossReserve	-3940939	usd
CY2023Q1	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	312174210	usd
CY2022Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	335332599	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4640905	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5715827	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	4159748	usd
CY2022Q4	refi	Risk Rating Five RiskRatingFive		usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	1204412	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	1668629	usd
CY2021Q4	refi	Risk Rating Five RiskRatingFive		usd
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41123
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3125132
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1680 Michigan Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
CY2022Q4	us-gaap	Other Receivables OtherReceivables	1018212	usd
CY2023Q1	refi	Related Party Receivables RelatedPartyReceivables	237885	usd
CY2023Q1	us-gaap	Assets Assets	322881377	usd
CY2022Q4	us-gaap	Assets Assets	343271050	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	37500000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	58000000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8667701	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	13618591	usd
CY2023Q1	us-gaap	Management Fee Payable ManagementFeePayable	2138005	usd
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	3295600	usd
CY2023Q1	refi	Related Party Payables RelatedPartyPayables	1270126	usd
CY2022Q4	refi	Related Party Payables RelatedPartyPayables	1397515	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	962153	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1058128	usd
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	220064	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1868193	usd
CY2023Q1	us-gaap	Liabilities Liabilities	50758049	usd
CY2022Q4	us-gaap	Liabilities Liabilities	79238027	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18088683	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18088683	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17766936	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17766936	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	180887	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	176859	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	274925072	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	268995848	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2982631	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5139684	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	272123328	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	264033023	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	322881377	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	343271050	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16527304	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9833053	usd
CY2023Q1	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	-1618296	usd
CY2022Q1	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	-72268	usd
CY2023Q1	us-gaap	Revenues Revenues	14909008	usd
CY2022Q1	us-gaap	Revenues Revenues	9760785	usd
CY2023Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	2138005	usd
CY2022Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	671505	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1274825	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	556141	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	569375	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	556904	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	138335	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	120940	usd
CY2023Q1	refi	Provision For Current Expected Credit Losses ProvisionForCurrentExpectedCreditLosses	96119	usd
CY2022Q1	refi	Provision For Current Expected Credit Losses ProvisionForCurrentExpectedCreditLosses	51343	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4216659	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1956833	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10692349	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7803952	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	10692349	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	7803952	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.6
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.6
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17879444	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17641090	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17960103	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17737975	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	264033023	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5794847	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	139389	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	8536280	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	10692349	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	272123328	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	264077968	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4481556	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	121915	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	7100875	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	7803952	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	269384516	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	10692349	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	7803952	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	908873	usd
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	894087	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2256228	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	970569	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	96119	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	48296	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	167304	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	72268	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	138335	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	120940	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2955336	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	175960	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19507	usd
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	10053	usd
CY2023Q1	refi	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	-1648129	usd
CY2022Q1	refi	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	-3084470	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-127389	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	237885	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1157595	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-233618	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-81098	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	358933	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1702067	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3035632	usd
CY2023Q1	refi	Issuance Of And Fundings Of Loans IssuanceOfAndFundingsOfLoans	32941660	usd
CY2022Q1	refi	Issuance Of And Fundings Of Loans IssuanceOfAndFundingsOfLoans	82794575	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	13399712	usd
CY2023Q1	refi	Proceeds From Repayment Of Loan To Purchase Common Stock ProceedsFromRepaymentOfLoanToPurchaseCommonStock	44858834	usd
CY2022Q1	refi	Proceeds From Repayment Of Loan To Purchase Common Stock ProceedsFromRepaymentOfLoanToPurchaseCommonStock	5619201	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25316886	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-77175374	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000010	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4505664	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	28500000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	49000000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	13486186	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	4512329	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2988	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	104711	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	23941	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28093875	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-30606	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1074922	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-74170348	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5715827	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80248526	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4640905	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6078178	usd
CY2022Q1	refi	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	3919974	usd
CY2023Q1	refi	Oid Withheldfrom Funding Of Loans OIDWithheldfromFundingOfLoans	1118340	usd
CY2022Q1	refi	Oid Withheldfrom Funding Of Loans OIDWithheldfromFundingOfLoans	1128415	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8667701	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7100066	usd
CY2023Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1363742	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates in the Preparation of Consolidated Financial Statements</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt"> </span></p>
CY2023Q1	refi	Least Percentage LeastPercentage	0.90	pure
CY2023Q1	refi	Taxable Income Percentage TaxableIncomePercentage	1	pure
CY2023Q1	refi	Ordinary Income Percentage OrdinaryIncomePercentage	0.85	pure
CY2023Q1	us-gaap	Derivative Net Assets Percentage DerivativeNetAssetsPercentage	0.95	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.04	pure
CY2023Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.90	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.04	pure
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Reclassifications</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain prior period amounts have been reclassified to conform to the current period presentation. Interest expense was previously presented as an operating expense and has been reclassified as a reduction to net interest income on the consolidated statements of income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These reclassifications do not result in any changes to previously reported total assets, stockholder’s equity, and net income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt; "> </span></p>
CY2023Q1	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	24	usd
CY2022	us-gaap	Loan Portfolio Expense LoanPortfolioExpense	22	usd
CY2023Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	328000000	usd
CY2022Q4	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	320200000	usd
CY2023Q1	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	351400000	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	343000000	usd
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	34100000	usd
CY2023Q1	refi	Portfolio Percentage PortfolioPercentage	0.88	pure
CY2022Q4	refi	Portfolio Percentage PortfolioPercentage	0.831	pure
CY2023Q1	refi	Loan Carrying Value LoanCarryingValue	278100000	usd
CY2022Q4	refi	Loan Carrying Value LoanCarryingValue	281600000	usd
CY2023Q1	refi	Remaining Portfolio Percentage RemainingPortfolioPercentage	0.12	pure
CY2022Q4	refi	Remaining Portfolio Percentage RemainingPortfolioPercentage	0.169	pure
CY2023Q1	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	38100000	usd
CY2022Q4	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	57700000	usd
CY2023Q1	refi	Total Loans Held At Carrying Value Original Issue Discount TotalLoansHeldAtCarryingValueOriginalIssueDiscount	-3965263	usd
CY2022	refi	Total Loans Held At Carrying Value Original Issue Discount TotalLoansHeldAtCarryingValueOriginalIssueDiscount	-3755796	usd
CY2023Q1	refi	Outstanding Principal OutstandingPrincipal	320191407	usd
CY2023Q1	refi	Original Issue Premium Discount OriginalIssuePremiumDiscount	-3965263	usd
CY2023Q1	refi	Debt Instrument Carrying Value DebtInstrumentCarryingValue	312174210	usd
CY2023Q1	refi	Loan Interest Rate Stated Percentage LoanInterestRateStatedPercentage	0.39	pure
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02	pure
CY2023Q1	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	307260513	usd
CY2022Q4	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	329237824	usd
CY2023Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	8965632	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	10035714	usd
CY2023Q1	us-gaap	Additional Liability Long Duration Insurance Current Weighted Average Discount Rate AdditionalLiabilityLongDurationInsuranceCurrentWeightedAverageDiscountRate	0.1753	pure
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	307260513	usd
CY2023Q1	refi	Primary Valuation Techniques PrimaryValuationTechniques	Yield analysis
CY2023Q1	us-gaap	Fair Value Measurements Sensitivity Analysis Description FairValueMeasurementsSensitivityAnalysisDescription	Market yield
CY2023Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.1753	pure
CY2023Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	307260513	usd
CY2021Q1	refi	Risk Rating One RiskRatingOne	235205	usd
CY2021Q4	refi	Risk Rating One RiskRatingOne	274406	usd
CY2023Q1	refi	Risk Rating Two RiskRatingTwo	13595388	usd
CY2022Q1	refi	Risk Rating Two RiskRatingTwo	124333205	usd
CY2021Q1	refi	Risk Rating Two RiskRatingTwo	71790767	usd
CY2022Q4	refi	Risk Rating Two RiskRatingTwo	94467449	usd
CY2021Q4	refi	Risk Rating Two RiskRatingTwo	88444868	usd
CY2020Q4	refi	Risk Rating Two RiskRatingTwo	29140546	usd
CY2022Q1	refi	Risk Rating Three RiskRatingThree	12525206	usd
CY2021Q1	refi	Risk Rating Three RiskRatingThree	65657524	usd
CY2022Q4	refi	Risk Rating Three RiskRatingThree	30415113	usd
CY2021Q4	refi	Risk Rating Three RiskRatingThree	83131444	usd
CY2021Q1	refi	Risk Rating Four RiskRatingFour	28088849	usd
CY2021Q4	refi	Risk Rating Four RiskRatingFour	13399712	usd
CY2023Q1	refi	Risk Rating RiskRating	13595388	usd
CY2022Q1	refi	Risk Rating RiskRating	136858411	usd
CY2021Q1	refi	Risk Rating RiskRating	165772345	usd
CY2022Q4	refi	Risk Rating RiskRating	124882562	usd
CY2021Q4	refi	Risk Rating RiskRating	185250430	usd
CY2020Q4	refi	Risk Rating RiskRating	29140546	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4035354	usd
CY2023Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	96119	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4131473	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	147949	usd
CY2022Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	51343	usd
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	199292	usd
CY2023Q1	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	4159748	usd
CY2022Q4	us-gaap	Interest Receivable Noncurrent InterestReceivableNoncurrent	1204412	usd
CY2023Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	4113589	usd
CY2022Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	1203330	usd
CY2023Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	33548	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1082	usd
CY2023Q1	refi	Unused Fee Receivable UnusedFeeReceivable	12611	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	4159748	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	1204412	usd
CY2023Q1	refi	Senior Term Loan SeniorTermLoan	4159748	usd
CY2023Q1	refi	Principal Receivable PrincipalReceivable	923734	usd
CY2023Q1	refi	Interest Receivable Total InterestReceivableTotal	5083482	usd
CY2022	refi	Senior Term Loan SeniorTermLoan	1204412	usd
CY2022	refi	Interest Receivable Total InterestReceivableTotal	1204412	usd
CY2022Q4	refi	Interest Reserves InterestReserves	1868193	usd
CY2020Q4	refi	Interest Reserves InterestReserves	6636553	usd
CY2021	refi	New Reserves NewReserves	9049834	usd
CY2023Q1	refi	Reserve Disbursed ReserveDisbursed	-1648129	usd
CY2021	refi	Reserve Disbursed ReserveDisbursed	-13818194	usd
CY2023Q1	refi	Interest Reserves InterestReserves	220064	usd
CY2021Q4	refi	Interest Reserves InterestReserves	1868193	usd
CY2021Q2	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	10000000	usd
CY2021Q2	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	100000	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	On December 16, 2021, CAL entered into an amended and restated Revolving Loan agreement (the “First Amendment and Restatement”). The First Amendment and Restatement increased the loan commitment from $10,000,000 to $45,000,000 and decreased the interest rate, from the greater of the (1) Prime Rate plus 1.00% and (2) 4.75% to the greater of (1) the Prime Rate plus the applicable margin and (2) 3.25%. The applicable margin is derived from a floating rate grid based upon the ratio of debt to equity of CAL and increases from 0% at a ratio of 0.25 to 1 to 1.25% at a ratio of 1.5 to 1. The First Amendment and Restatement also extended the maturity date from February 12, 2023 to the earlier of (i) December 16, 2023 and (ii) the date on which the Revolving Loan is terminated pursuant to the terms of the Revolving Loan agreement.
CY2023Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	859500	usd
CY2022Q2	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	177261	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	323779	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2988	usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	641279	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	805596	usd
CY2023Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan FinancingReceivableRevolvingConvertedToTermLoan	37500000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0775	pure
CY2023Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0025	pure
CY2023Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan Writeoff FinancingReceivableRevolvingConvertedToTermLoanWriteoff	55000000	usd
CY2023Q1	us-gaap	Long Term Debt Description LongTermDebtDescription	Additionally, the Company must comply with certain financial covenants including: (1) maximum capital expenditures of $150,000, (2) maintaining a debt service coverage ratio greater than 1.35 to 1, and (3) maintaining a leverage ratio less than 1.50 to 1. As of March 31, 2023, the Company is in compliance with all financial covenants with respect to the Revolving Loan.
CY2023Q1	us-gaap	Interest Expense InterestExpense	1440992	usd
CY2023Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	-10000	usd
CY2023Q1	refi	Amortization Of Debt Issue Costs1 AmortizationOfDebtIssueCosts1	-167304	usd
CY2022Q1	refi	Amortization Of Debt Issue Costs1 AmortizationOfDebtIssueCosts1	-72268	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1618296	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	72268	usd
CY2023Q1	refi	Interest Percentage InterestPercentage	0.00375	pure
CY2023Q1	refi	Equity Percentage EquityPercentage	0.50	pure
CY2023Q1	us-gaap	Increase Decrease In Management And Incentive Fees Payable IncreaseDecreaseInManagementAndIncentiveFeesPayable	5000	usd
CY2022Q1	us-gaap	Increase Decrease In Management And Incentive Fees Payable IncreaseDecreaseInManagementAndIncentiveFeesPayable	717750	usd
CY2023Q1	us-gaap	Payment For Incentive Fee PaymentForIncentiveFee	1111206	usd
CY2022Q1	us-gaap	Payment For Incentive Fee PaymentForIncentiveFee	382143	usd
CY2023Q1	us-gaap	Property Management Fee Revenue PropertyManagementFeeRevenue	1031799	usd
CY2022Q1	us-gaap	Property Management Fee Revenue PropertyManagementFeeRevenue	1007112	usd
CY2023Q1	refi	Other Fees Earned And Paid To The Manager OtherFeesEarnedAndPaidToTheManager	-5000	usd
CY2022Q1	refi	Other Fees Earned And Paid To The Manager OtherFeesEarnedAndPaidToTheManager	-717750	usd
CY2023Q1	refi	Base Management Fees Net BaseManagementFeesNet	1026799	usd
CY2022Q1	refi	Base Management Fees Net BaseManagementFeesNet	289362	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1111206	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	382143	usd
CY2023Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	2138005	usd
CY2022Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	671505	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1176376	usd
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	411521	usd
CY2023Q1	us-gaap	Affiliate Costs AffiliateCosts	3314381	usd
CY2022Q1	us-gaap	Affiliate Costs AffiliateCosts	1083026	usd
CY2023Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	3400000	usd
CY2022	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	4700000	usd
CY2023Q1	us-gaap	Selling Expense SellingExpense	13700000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19000000	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	327954423	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	351367706	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	313720423	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	336323706	usd
CY2023Q1	us-gaap	Unused Commitments To Extend Credit UnusedCommitmentsToExtendCredit	14234000	usd
CY2022Q4	us-gaap	Unused Commitments To Extend Credit UnusedCommitmentsToExtendCredit	15044000	usd
CY2023Q1	refi	Commitments Total CommitmentsTotal	51734000	usd
CY2023Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	2400000	usd
CY2023Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	44500000	usd
CY2023Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	834000	usd
CY2023Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	4000000	usd
CY2022Q1	refi	Underwriters Shares Purchase UnderwritersSharesPurchase	302800	shares
CY2022Q1	refi	Common Stock Price Par Value CommonStockPriceParValue	16
CY2022Q1	refi	Additional Gross Proceeds AdditionalGrossProceeds	4844800	usd
CY2022Q1	refi	Additional Net Proceeds AdditionalNetProceeds	4505664	usd
CY2022Q1	refi	Under Commissions UnderCommissions	339136	usd
CY2023Q1	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	395779	shares
CY2023Q1	refi	Common Stock Price Par Value CommonStockPriceParValue	15.16
CY2023Q1	refi	Additional Gross Proceeds AdditionalGrossProceeds	6000000	usd
CY2021	refi	Restricted Common Stock Shares RestrictedCommonStockShares	98440	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	24880	shares
CY2023Q1	refi	Issued And Outstanding Shares Percentage IssuedAndOutstandingSharesPercentage	0.085	pure
CY2022	refi	Issued And Outstanding Shares Percentage IssuedAndOutstandingSharesPercentage	0.085	pure
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	417	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	3750	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	994539	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	472728	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	80984	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.71
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6952	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	16
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	417	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	16
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	73615	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.68
CY2019Q4	refi	Risk Rating Two RiskRatingTwo		usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	98440	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3750	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	16
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	94690	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	138335	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	120940	usd
CY2023Q1	us-gaap	Royalty Expense RoyaltyExpense	1100000	usd
CY2022Q1	us-gaap	Royalty Expense RoyaltyExpense	1600000	usd
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M6D
CY2023Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	10692349	usd
CY2022Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	7803952	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17879444	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17641090	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17960103	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17737975	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.6
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.6
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2023Q1	refi	Stockholders At Least Percentage StockholdersAtLeastPercentage	0.90	pure
CY2023Q1	refi	Reit Taxable Income Percentage REITTaxableIncomePercentage	1	pure
CY2023Q1	refi	Ordinary Income Percent OrdinaryIncomePercent	0.85	pure
CY2023Q1	refi	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.95	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
CY2023Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.90	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04	pure
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	0	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	0	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.47
CY2023Q1	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	8500000	usd
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	refi	Related Party Receivables RelatedPartyReceivables		usd
CY2022Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment		usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2023Q1	refi	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan		usd
CY2022Q1	us-gaap	Interest Paid Capitalized InterestPaidCapitalized		usd
CY2020Q1	refi	Risk Rating Two RiskRatingTwo		usd
CY2019Q1	refi	Risk Rating Two RiskRatingTwo		usd
CY2020Q4	refi	Risk Rating Five RiskRatingFive		usd
CY2019Q4	refi	Risk Rating Five RiskRatingFive		usd
CY2020Q1	refi	Risk Rating RiskRating		usd
CY2019Q1	refi	Risk Rating RiskRating		usd
CY2019Q4	refi	Risk Rating RiskRating		usd
CY2022Q4	refi	Unused Fee Receivable UnusedFeeReceivable		usd
CY2023Q1	refi	New Reserves NewReserves		usd
CY2022Q1	us-gaap	Interest Expense InterestExpense		usd
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit		usd
CY2023Q1	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear		usd
CY2023Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear		usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001867949

Files In Submission

Name	View Source	Status
0001213900-23-037447-index-headers.html	Edgar Link	pending
0001213900-23-037447-index.html	Edgar Link	pending
0001213900-23-037447.txt	Edgar Link	pending
0001213900-23-037447-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_chicago.htm	Edgar Link	pending
f10q0323ex31-2_chicago.htm	Edgar Link	pending
f10q0323ex32-1_chicago.htm	Edgar Link	pending
f10q0323ex32-2_chicago.htm	Edgar Link	pending
f10q0323_chicagoatl.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_chicagoatl_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
refi-20230331.xsd	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
refi-20230331_cal.xml	Edgar Link	unprocessable
refi-20230331_def.xml	Edgar Link	unprocessable
refi-20230331_lab.xml	Edgar Link	unprocessable
refi-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REFI
Chicago Atlantic Real Estate Finance, Inc. Stock $refi

2023 Q2 Form 10-Q Financial Statement

#000121390023037447 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REFI Chicago Atlantic Real Estate Finance, Inc. Stock $refi

2023 Q2 Form 10-Q Financial Statement

#000121390023037447 Filed on May 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REFI
Chicago Atlantic Real Estate Finance, Inc. Stock $refi